Microbiology Department, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK.
J Antimicrob Chemother. 2011 Oct;66(10):2288-94. doi: 10.1093/jac/dkr299. Epub 2011 Jul 25.
To determine the prevalence and antimicrobial susceptibility of carbapenemase-producing Enterobacteriaceae among hospitalized patients and outpatients attending two military hospitals in Rawalpindi, Pakistan, and to compare the performance of two chromogenic culture media for the isolation of these organisms.
Stool samples from 200 distinct patients were cultured on MacConkey agar and subsequently on two chromogenic media-Colorex KPC and a prototype chromogenic medium, ID Carba-designed for the isolation of carbapenemase-producing Enterobacteriaceae. All Gram-negative isolates growing on either chromogenic medium were investigated for carbapenemases by phenotypic and molecular methods. Producers were subjected to susceptibility testing with 40 antimicrobials by VITEK 2 or agar dilution.
In total, 64 NDM-1-positive isolates of Enterobacteriaceae, belonging to seven distinct species, were recovered from 37 (18.5%) of the stool samples. No other carbapenemase types were confirmed. Nineteen positive samples were identified among 70 from inpatients (prevalence 27.1%) and there were 18 positive samples among 130 from outpatients (prevalence 13.8%). Fifty-six isolates (87.5%) harbouring the NDM-1 enzyme were recovered on ID Carba compared with 41 isolates (64.1%) on Colorex KPC (P = 0.012). Multidrug resistance was prevalent, but no pan-resistant isolates were found, with most isolates susceptible in vitro to colistin (97%), mecillinam (95%), fosfomycin (94%), tigecycline (89%) and nitrofurantoin (78%).
This study shows a high prevalence of multidrug-resistant Enterobacteriaceae with the NDM-1 enzyme in Rawalpindi. The new chromogenic medium, ID Carba, was more sensitive than Colorex KPC and has potential as a screening medium for isolation of Enterobacteriaceae harbouring the NDM-1 enzyme.
确定巴基斯坦拉瓦尔品第的两家军队医院住院患者和门诊患者中产碳青霉烯酶肠杆菌科的流行率和抗菌药物敏感性,并比较两种显色培养基在分离这些生物体方面的性能。
对 200 名不同患者的粪便样本进行培养,先在麦康凯琼脂上培养,然后再在两种显色培养基上培养-显色培养基科雷克斯 KPC 和一种用于分离产碳青霉烯酶肠杆菌科的原型显色培养基 ID Carba。对两种显色培养基上生长的所有革兰氏阴性分离株均通过表型和分子方法进行碳青霉烯酶检测。通过 VITEK 2 或琼脂稀释法对产酶株进行 40 种抗菌药物的药敏试验。
总共从 37 份(18.5%)粪便样本中回收了属于七种不同种属的 64 株 NDM-1 阳性肠杆菌科。没有确认其他碳青霉烯酶类型。从 70 名住院患者的 19 份阳性样本(患病率 27.1%)和 130 名门诊患者的 18 份阳性样本(患病率 13.8%)中发现。在 ID Carba 上回收了 56 株(87.5%)携带 NDM-1 酶的分离株,而在科雷克斯 KPC 上回收了 41 株(64.1%)(P = 0.012)。多药耐药性很普遍,但未发现泛耐药株,大多数分离株对体外多粘菌素(97%)、美西林(95%)、磷霉素(94%)、替加环素(89%)和呋喃妥因(78%)敏感。
本研究显示拉瓦尔品第地区产 NDM-1 酶的多重耐药肠杆菌科的流行率很高。新型显色培养基 ID Carba 比科雷克斯 KPC 更敏感,具有作为分离携带 NDM-1 酶的肠杆菌科的筛选培养基的潜力。